Human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS) Infections and Infestations Unspecified human immunodeficiency virus [HIV] disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Individuals aged 16 years or older registering at study practices, either sex 2. Individuals able to undertake the pre-test discussion in English or with a suitable translator
Exclusion criteria
Exclusion criteria: 1. Aged under 16 years 2. Individuals with limited English abilities, who are unable to understand the info sheet or, who are unable to engage with the pre-test discussion for HIV testing 3. Known HIV positive patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rates of new HIV diagnoses: numbers of rapid and standard HIV tests done in new patient health checks Outcomes are measured quarterly. | — |
Secondary
| Measure | Time frame |
|---|---|
| Immunological outcomes: 1. Numbers of patients diagnosed during early HIV infection defined as CD4 count higher than 200 cells per cubic millimetre blood Viral outcomes: 2. HIV viral load, clade and genotype of the virus at the time of diagnosis as predictors of disease progression Health service use: 3. Numbers of registering patients 4. Numbers of standard HIV tests done opportunistically 5. Numbers of New Patient Health Checks carried out Economic outcomes: 6. Cost-effectiveness of the intervention compared to standard of care Outcomes are measured quarterly. | — |
Countries
United Kingdom